Antiviral drug-resistance typing reveals compartmentalization and dynamics of acyclovir-Resistant herpes simplex virus type-2 (HSV-2) in a case of neonatal herpes

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue 2, 2014, Pages

  Bache, Manon ^a   Andrei, Graciela ^b   Bindl, Lutz ^a   Bofferding, Léon ^a   Bottu, Jean ^a   Géron, Christine ^a   Neuhäuser, Christoph ^a   Gillemot, Sarah ^b   Fiten, Pierre ^b   Opdenakker, Ghislain ^b   Snoeck, Robert ^b  

^a Centre Hospitalier   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acyclovir resistance; Neonatal HSV; Virus compartmentalization

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; AMPICILLIN; CEFTAZIDIME; CHICKENPOX VACCINE; CIDOFOVIR; FOSCARNET SODIUM; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; LACTATE DEHYDROGENASE; VANCOMYCIN; VIRUS DNA;

ANTIVIRAL RESISTANCE; APNEA; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CASE REPORT; CELL COMPARTMENTALIZATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DNA POLYMERASE GENE; FEMALE; FOLLOW UP; GENOTYPE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; LEUKOCYTOSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PHENOTYPE; PNEUMONIA; POLYMERASE CHAIN REACTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN DEFECT; THORAX RADIOGRAPHY; THYMIDINE KINASE GENE; TRACHEAL ASPIRATION PROCEDURE; VESICULAR RASH; VIRAL CLEARANCE; VIRUS GENE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; BRONCHOPNEUMONIA; CEREBROSPINAL FLUID ANALYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER FUNCTION TEST; NONHUMAN; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS SYNDROME; VIRUS ISOLATION; VIRUS TYPING;

EID: 84949125878     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pit045     Document Type: Article

References (16)

1. Thompson C, Whitley R. Neonatal herpes simplex virus infections: Where are we now? Adv Exp Med Biol 2011; 697:221-30.
2. Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158:109-16.
3. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res 2009; 83:207-13.
4. Andrei G, Snoeck R, De Clercq E, Esnouf R, Fiten P, Opdenakker G. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J Gen Virol 2000; 81:639-48.
5. Andrei G, Balzarini J, Fiten P, De Clercq E, Opdenakker G, Snoeck R. Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin. J Virol 2005; 79:5863-9.
6. Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management. Antimicrob Agents Chemother 2011; 55:459-72.
7. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108:230-8.
8. Kimberlin DW. Management of HSV encephalitis in adults and neonates: Diagnosis, prognosis and treatment. Herpes 2007; 14: 11-6.
9. Nyquist AC, Rotbart HA, Cotton M, et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr 1994; 124:967-71.
10. Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial. Pediatr Infect Dis J 1996; 15:247-54.
11. Levin MJ, Weinberg A, Leary JJ, Sarisky RT. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J 2001; 20: 1094-7.
12. Oram RJ, Marcellino D, Strauss D, et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis 2000; 181:1458-61.
13. Kakiuchi S, Nonoyama S, Wakamatsu H, et al. Neonatal herpes encephalitis caused by a virologically confirmed acyclovir resistant herpes simplex virus type 1. J Clin Microbiol 2013; 51: 356-9.
14. Bower JR, Mao H, Durishin C, et al. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J Virol 1999; 73:3843-53.
15. Malm G. Neonatal herpes simplex virus infection. Semin Fetal Neonatal Med 2009; 14:204-8.
16. Robinson JL, Vaudry WL, Forgie SE, Lee BE. Prevention, recognition and management of neonatal HSV infections. Expert Rev Anti Infect Ther 2012; 10:675-85.